[
  {
    "ts": "2025-08-06T19:48:00+00:00",
    "headline": "FTC Files Lawsuit to Block Edwards Lifesciences’ Purchase of JenaValve Technology",
    "summary": "The FTC said the acquisition would limit competition in the aortic regurgitation device market, curbing innovation and potentially raising prices for U.S. consumers.",
    "url": "https://www.wsj.com/business/deals/ftc-files-lawsuit-to-block-edwards-lifesciences-purchase-of-jenavalve-technology-911f4d91?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "7788cc8e-465b-3f98-bfff-74b7d9f4bb08",
      "content": {
        "id": "7788cc8e-465b-3f98-bfff-74b7d9f4bb08",
        "contentType": "STORY",
        "title": "FTC Files Lawsuit to Block Edwards Lifesciences’ Purchase of JenaValve Technology",
        "description": "",
        "summary": "The FTC said the acquisition would limit competition in the aortic regurgitation device market, curbing innovation and potentially raising prices for U.S. consumers.",
        "pubDate": "2025-08-06T19:48:00Z",
        "displayTime": "2025-08-06T19:48:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7788cc8e-465b-3f98-bfff-74b7d9f4bb08/ftc-files-lawsuit-to-block.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/4e1e376b49c6478de23b9791621691b5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CYZWQB9M1ZBNCM3AaZx5wg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/4e1e376b49c6478de23b9791621691b5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HFClq4yDuvl6kl449S4haQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/4e1e376b49c6478de23b9791621691b5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/deals/ftc-files-lawsuit-to-block-edwards-lifesciences-purchase-of-jenavalve-technology-911f4d91?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-06T18:17:00+00:00",
    "headline": "JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition",
    "summary": "IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition by Edwards Lifesciences. JenaValve respectfully disagrees with the FTC's decision and remains committed to completing the acquisition. JenaValve remains confident in both its rationale for the transaction and the value it will bring to the hundreds of thousands of patients suffering from aortic regurgitation. JenaVal",
    "url": "https://finance.yahoo.com/news/jenavalve-responds-ftc-action-against-181700443.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "803237b9-f1ac-32ae-b41b-8ff9fa323240",
      "content": {
        "id": "803237b9-f1ac-32ae-b41b-8ff9fa323240",
        "contentType": "STORY",
        "title": "JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition",
        "description": "",
        "summary": "IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition by Edwards Lifesciences. JenaValve respectfully disagrees with the FTC's decision and remains committed to completing the acquisition. JenaValve remains confident in both its rationale for the transaction and the value it will bring to the hundreds of thousands of patients suffering from aortic regurgitation. JenaVal",
        "pubDate": "2025-08-06T18:17:00Z",
        "displayTime": "2025-08-06T18:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/f823f7044a6e05a53192bb6ffe7f47df",
          "originalWidth": 4083,
          "originalHeight": 959,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BIVR5iqZQmXps3md1UAGdQ--~B/aD05NTk7dz00MDgzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/f823f7044a6e05a53192bb6ffe7f47df.cf.webp",
              "width": 4083,
              "height": 959,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GSvtN7jjNqPHT4AO.JRtrA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f823f7044a6e05a53192bb6ffe7f47df.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jenavalve-responds-ftc-action-against-181700443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jenavalve-responds-ftc-action-against-181700443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-06T17:41:00+00:00",
    "headline": "FTC seeks to block Edwards Lifesciences' acquisition of JenaValve",
    "summary": "Edwards and JenaValve are the only two companies in the United States currently conducting clinical trials on transcatheter aortic valve replacement devices, which are used to treat a condition called aortic regurgitation where the heart’s aortic valve does not close properly, the FTC said in its lawsuit.  “The FTC is taking action to stop this anticompetitive deal and ensure that JenaValve and Edwards’ JC Medical subsidiary continue competing to innovate, expand treatment eligibility, and keep down costs,” Daniel Guarnera, head of the FTC’s bureau of competition, said in a statement.",
    "url": "https://finance.yahoo.com/news/ftc-seeks-block-edwards-lifesciences-174100944.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "fe2bf50e-818d-30a5-9815-1149df98835b",
      "content": {
        "id": "fe2bf50e-818d-30a5-9815-1149df98835b",
        "contentType": "STORY",
        "title": "FTC seeks to block Edwards Lifesciences' acquisition of JenaValve",
        "description": "",
        "summary": "Edwards and JenaValve are the only two companies in the United States currently conducting clinical trials on transcatheter aortic valve replacement devices, which are used to treat a condition called aortic regurgitation where the heart’s aortic valve does not close properly, the FTC said in its lawsuit.  “The FTC is taking action to stop this anticompetitive deal and ensure that JenaValve and Edwards’ JC Medical subsidiary continue competing to innovate, expand treatment eligibility, and keep down costs,” Daniel Guarnera, head of the FTC’s bureau of competition, said in a statement.",
        "pubDate": "2025-08-06T17:41:00Z",
        "displayTime": "2025-08-06T17:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters-finance.com/bdda13a12e476c497320da8819263da2",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: Illustration shows United States Federal Trade Commission logo and U.S. flag",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qan649.yM_IE3BktW2kWNQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/bdda13a12e476c497320da8819263da2.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fWFKmWm10_jWb339D23GOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/bdda13a12e476c497320da8819263da2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ftc-seeks-block-edwards-lifesciences-174100944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ftc-seeks-block-edwards-lifesciences-174100944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-06T17:40:00+00:00",
    "headline": "Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve",
    "summary": "IRVINE, Calif., August 06, 2025--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition of JenaValve Technology.",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-comments-ftc-action-174000345.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "431c05ca-fad9-3b6e-97ed-ed3a89fa58a3",
      "content": {
        "id": "431c05ca-fad9-3b6e-97ed-ed3a89fa58a3",
        "contentType": "STORY",
        "title": "Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve",
        "description": "",
        "summary": "IRVINE, Calif., August 06, 2025--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition of JenaValve Technology.",
        "pubDate": "2025-08-06T17:40:00Z",
        "displayTime": "2025-08-06T17:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/6e947969b9e3850cf8ae34dadd89cbab",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GS_NxaY0Hi0_RrbteyT4og--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6e947969b9e3850cf8ae34dadd89cbab.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uRMcqZyMPnuiB3zDAYwpgw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6e947969b9e3850cf8ae34dadd89cbab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-comments-ftc-action-174000345.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-comments-ftc-action-174000345.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]